| Drug Name |
Prednisolone acetate |
| Drug ID |
BADD_D01832 |
| Description |
Prednisolone acetate is a [prednisolone] molecule bound to an acetate functional group by an ester bond.[L9449]
Prednisolone acetate was granted FDA approval in 1955.[L9449] |
| Indications and Usage |
Prednisolone acetate is indicated as an anti-inflammatory or immunosuppressive agent for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, or infectious conditions.[L9449] Prednisolone acetate is also indicated in organ transplant patients, as well as endocrine or neoplastic conditions.[L9449] |
| Marketing Status |
approved; vet_approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB15566
|
| KEGG ID |
D00980
|
| MeSH ID |
C009935
|
| PubChem ID |
5834
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
38779-0152; 62991-1692; 50090-0559; 50090-1912; 50090-5275; 61314-637; 49452-5990; 82298-107; 11980-180; 60758-119; 60722-3006; 82298-108; 52128-150; 11980-174; 46439-8761; 51552-0027; 64958-0048; 76420-204; 22552-0044; 68071-2222 |
| UNII |
8B2807733D
|
| Synonyms |
prednisolone acetate | prednisolone 21-acetate | pred forte | Scherisolone-Kristall suspension |
